Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical Max Drawdown (5Y) : 69.08% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 69.08% |
| June 30, 2026 | 69.08% |
| May 31, 2026 | 69.08% |
| April 30, 2026 | 69.08% |
| March 31, 2026 | 69.08% |
| February 28, 2026 | 69.08% |
| January 31, 2026 | 69.08% |
| December 31, 2025 | 69.08% |
| November 30, 2025 | 69.08% |
| October 31, 2025 | 69.08% |
| September 30, 2025 | 69.08% |
| August 31, 2025 | 69.08% |
| July 31, 2025 | 69.08% |
| June 30, 2025 | 69.08% |
| May 31, 2025 | 69.08% |
| April 30, 2025 | 69.08% |
| March 31, 2025 | 69.08% |
| February 28, 2025 | 69.08% |
| January 31, 2025 | 69.08% |
| December 31, 2024 | 69.08% |
| November 30, 2024 | 69.08% |
| October 31, 2024 | 69.08% |
| September 30, 2024 | 69.08% |
| August 31, 2024 | 69.08% |
| July 31, 2024 | 69.08% |
| Date | Value |
|---|---|
| June 30, 2024 | 69.08% |
| May 31, 2024 | 69.08% |
| April 30, 2024 | 69.08% |
| March 31, 2024 | 69.08% |
| February 29, 2024 | 69.08% |
| January 31, 2024 | 69.08% |
| December 31, 2023 | 69.08% |
| November 30, 2023 | 69.08% |
| October 31, 2023 | 69.08% |
| September 30, 2023 | 69.08% |
| August 31, 2023 | 69.08% |
| July 31, 2023 | 69.08% |
| June 30, 2023 | 69.08% |
| May 31, 2023 | 69.08% |
| April 30, 2023 | 69.08% |
| March 31, 2023 | 69.08% |
| February 28, 2023 | 69.08% |
| January 31, 2023 | 69.08% |
| December 31, 2022 | 69.08% |
| November 30, 2022 | 69.08% |
| October 31, 2022 | 68.93% |
| September 30, 2022 | 68.26% |
| August 31, 2022 | 65.66% |
| July 31, 2022 | 65.28% |
| June 30, 2022 | 65.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 50.60% |
| Daiichi Sankyo Co., Ltd. | 64.07% |
| Eisai Co., Ltd. | 95.02% |
| Chugai Pharmaceutical Co., Ltd. | 59.68% |
| Ono Pharmaceutical Co., Ltd. | 69.70% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.67 |
| Beta (5Y) | 0.4759 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 28.45% |
| Historical Sharpe Ratio (5Y) | -0.2209 |
| Historical Sortino (5Y) | -0.3771 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 11.78% |